XRP Healthcare, a fast-growing innovator in AI-driven healthcare and mergers & acquisitions, has announced plans to go public by Q3 2025.
The company confirmed today that it is accelerating its initial public offering (IPO) timeline, moving the listing from 2027 to the third quarter of this year on a Canadian stock exchange. This bold move aims to fast-track expansion, unlock new investment opportunities, and solidify its position as a global leader in healthcare transformation.
The decision follows a series of strategic developments, including the acquisition of Pharma Ville, a pharmacy chain with five wholesale and two retail locations in Uganda. This acquisition grants XRP Healthcare direct access to vital pharmaceutical infrastructure and strengthens its foothold in Africa’s projected $259 billion healthcare market.
The IPO is being guided by ARC Group, a globally recognized capital markets advisory firm. Abraham Cinta, CEO of ARC Group, commented in XRP Healthcare’s Special Edition Magazine:
“The visibility of being a public company is immense and could exponentially transform their business, perhaps by a factor of 10 or even 100.”
Charles Chong, Vice President of EMEA Capital Markets at ARC Group, added: “Listing in Canada is just one step. The long-term vision includes a U.S. listing within five years to enhance investor exposure and global market visibility.”
Whitney Lynn, Chairman of XRP Healthcare, who has over 45 years of M&A experience with more than $10 billion in value creation, emphasized:
“XRP Healthcare is at a pivotal moment. Our IPO process has been in motion for months, and we’re on track to be publicly listed before September. We are accelerating our M&A strategy, starting with our pharmacy chain acquisition in Uganda.”
Following the Pharma Ville acquisition, XRP Healthcare has partnered with leading pharmaceutical and healthcare providers to strengthen its distribution and operations across Africa. Key partners include: Incepta Pharmaceuticals – Generics and vaccines; Ascensia Diabetes Care, Diabetes management; Universal Corporation, Medical applications of leaf tobacco and Naari, Women’s health pharmaceuticals.
Others are Amanta Healthcare, Sterile injectables and IV infusions; Marie Stopes Uganda, Reproductive health and family planning; Medrul, Wound care and first-aid solutions AND Toros Group, Pharmaceutical distribution.
Additionally, XRP Healthcare has secured an exclusive distribution agreement with Isansys Lifecare to deploy the Patient Status Engine (PSE) across Africa. This wireless, AI-driven medical platform integrates advanced sensors, deep learning, and predictive analytics to enable earlier interventions, home-based care, and paperless wards, easing the burden on hospitals and healthcare staff.
Supporting this vision is the XRPH AI App, a multilingual digital health assistant available on Google Play and the Apple App Store. Designed to improve healthcare access, the app provides AI-generated medical guidance in multiple languages, making it an essential tool in regions with limited healthcare infrastructure.
Recent updates include an image upload feature for AI-assisted analysis of visible symptoms like rashes, swelling, and fungal infections. A “Doctor Search & Connect” feature is set to launch next quarter, enabling users to find licensed medical professionals nearby.
With trademark protection secured in the UK, EU, UAE, and Uganda, XRP Healthcare is building a strong, recognizable brand in digital healthcare. The company’s rapid expansion strategy is particularly well-suited to Africa, where 57% of Uganda’s 46 million people rely on private for-profit healthcare providers, and over 6,000 fragmented operators exist.
Laban Roomes, COO, stated: “Pharma Ville wasn’t just a nationwide acquisition—it’s a cornerstone in our IPO strategy. With five wholesale and two retail pharmacies in Uganda secured, we’ve built the foundation for scaling up. We’re on track to list before autumn, unlocking capital to drive regional expansion and transform healthcare across Africa.”
Kain Roomes, CEO, added: “Africa’s private healthcare sector accounts for 50% of total service delivery. Our model consolidates and modernizes this space, improving access and quality. The IPO will accelerate our mission.”
XRP Healthcare plans to expand into Kenya and Rwanda, leveraging the legal, operational, and regulatory frameworks established in Uganda.
